Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
Philip J. Mease, Désirée M F M van der Heijde, Christopher T. Ritchlin, Masato Okada, Raquel Cuchacovich, Catherine L Shuler and 4 more
- Rank
- 11 of 787
- Percentile
- top 1.4%
- Where
- Annals of the Rheumatic Diseases, 2016
- Citations
- 581
From the 2016 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.